m+Medelevator.RU
← Поиск публикаций
Leukemia & lymphoma · 2021

Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mou Eric, Falchi Lorenzo, Sundaram Vandana, Abramson Jeremy S, Balassanian Ronald, Beygi Sara, Fitzpatrick Megan J, Frank Annabel Kate, Gupta Srishti, Lin Oscar, Reed Joshua R, Long Steven R, Ly Amy, Menke Joshua R, Reed Daniel R, Ruiz-Cordero Roberto, Volaric Ashley K, Xie Yi, Wang Linlin, Wen Kwun Wah, Zadeh Sara L, Natkunam Yasodha, Cheung Matthew C, Gratzinger Dita, Cyto-Heme Institutional Collaborative (CHIC) consortium

Аннотация

Diagnosis of histologic transformation (HT) of follicular lymphoma (FL) requires tissue biopsy. While surgical biopsy represents the gold standard, less invasive procedures such as fine-needle aspiration biopsy (FNAB) and core needle biopsy (CNB) are frequently performed. In this retrospective multi-institutional study including 269 patients with FL and suspected HT, the median time from initial clinical suspicion to final diagnostic biopsy was similar whether the workup began with FNAB, CNB, or surgical biopsy (4, 9, and 6 days, respectively; p=.27), despite more subsequent biopsies performed following initial FNAB. Periprocedural complications were uniformly minimal. Biopsy-proven HT was more common in the initial surgery group and in workups including positron emission tomography/computed tomography (PET/CT). Our findings, derived from US academic centers with specialized procedural and pathology expertise, suggest that FNAB, CNB, and surgical biopsy are all viable initial diagnostic procedures that can inform clinical decision-making in select FL patients with suspected HT.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты